C ongenital heart disease (CHD), which is present in around 1.0% (1 in 110) of all live births in the United States, is the most common birth defect. [1] [2] [3] [4] [5] Defined generally as malformations present at birth that involve the heart or major associated blood vessels, CHD includes a remarkably heterogeneous group of chronic conditions, with very different phenotypes, prevalence, risk factors, and outcomes. CHD is a significant contributor to birth-defect-related morbidity, mortality, and healthcare costs 6 in early life and increasingly among adolescents and adults. 7 Because of their broad impact at the population level, a public health approach is needed to address the challenges of these common, critical, and costly conditions. 8 We sought to create a framework to address CHD from a population-based perspective, to serve as a model for a public health agenda for the United States, with a goal of improving the lives of those with or at risk for CHD. This framework is complementary to previous work outlining the Centers for Disease Control and Prevention's scientific priorities related to CHD, 9 because implementation strategies are also needed in addition to addressing gaps in scientific knowledge.
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The CHD framework is a public health model for addressing disease at the population level, which emphasizes monitoring, interventions, and optimizing outcomes at the population level. Core components of a public health model are: (1) identifying or monitoring the occurrence and outcomes of a condition over time and among different subgroups in the population; (2) investigating factors that impact occurrence and outcomes, specifically causes of disease and modifiers of prognosis; (3) developing interventions and policies to reduce risks and improve outcomes; (4) implementing interventions and policies; and (5) evaluating the effectiveness of such interventions and policies. 12 These components are interconnected in that improvements in each component lead to improvements in the entire framework and success in addressing public health challenges. The main features of the public health framework for CHD, presented in language appropriate for a lay audience, have three key pillars: Identify and Investigate, Develop Interventions and Policies, and Implement and Evaluate (Figure 1 ). The scope encompasses everyone at risk for CHD or living with CHD to underscore the need for equitable and universal access to care delivery and services. In the following sections, components are discussed, along with key issues identified by the Congenital Heart Public Health Consortium (CHPHC) for improved outcomes. Key opportunities to advance a public health agenda for CHD are listed (Table 1) .
Identify and Investigate
Identification includes monitoring both prevalence and outcomes-CHD prevalence at birth and across the life span as well as survival, morbidity, and disability. At any age, prevalence depends on both birth prevalence and survival. Disparities in survival based on race or ethnicity, or associated factors such as socioeconomic status or parental education, impact the prevalence of specific types of CHD at different ages. 13 Reliable population-based monitoring of CHD requires several elements: operational case definitions that are clear and consistent; a source population that is well defined in time and space; and a sustainable ascertainment system of CHD occurrence and outcomes that is accurate, complete, and timely. In the United States, there are well-established programs for monitoring CHD at birth. The National Birth Defects Prevention Network has provided guidance for monitoring 16 specific types of CHD among births. 14 In contrast, population-based monitoring of CHD beyond infancy and childhood nationwide is much less developed and has significant gaps. 15 These gaps pose a major challenge for population-based public health programs aimed at addressing the needs of people with CHD across the life span. A fragmented system of care for those with CHD contributes to this challenge, particularly for adults. The situation in the United States is in contrast to a few successful models of population-based monitoring of CHD throughout the life span. 16, 17 Investigation includes epidemiological research to understand key elements such as: (1) factors that increase or decrease the risk of developing CHD and (2) factors, including genetic factors, that modify outcomes in those born with CHD, including survival, health, quality of life, societal integration, and other long-term outcomes, such as neurodevelopmental and psychosocial outcomes and reproductive health. Currently, Figure 1 . Congenital heart public health consortium public health framework for congenital heart disease. most causes of CHD are not known. A large fraction of CHD is thought to have a multifactorial etiology-that is, many cases are thought to be caused by a variable and mostly undetermined combination of environmental and genetic factors. 18, 19 Determining the nature and contribution of these factors to the risk of developing CHD has proven remarkably difficult. Nevertheless, such research is crucial to design evidence-based interventions aimed at primary prevention (reducing the number of newborn cases of CHD) 9 and secondary prevention (reducing complications and improving outcomes for the many infants who continue to be born with CHD). 20 The population of adolescents and adults with CHD continues to grow rapidly, underscoring a need to investigate modifiable population-level factors that can be leveraged to improve outcomes across the life span. Recent evidence suggests ongoing risk for early mortality, even after repair of less-severe CHD lesions. 7 Multiple data sets are available and potentially useful to examine CHD outcomes and health services utilization. 
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Encourage insurance availability for congenital heart disease care across the life span, including specialty care when necessary 11 Develop programs to assure that all people with congenital heart disease have primary care in a patient-centered medical home that includes supports to family members and caregivers
Implement and Evaluate

Prevention education
12
Target educational programs to individuals and the medical community to disseminate information about proven and effective strategies to prevent congenital heart disease Quality care
13 Project workforce necessary to care for the growing population of adults with congenital heart disease and adjust the number of fellowship training programs and positions accordingly 14 Optimize healthcare systems with adequate specialty care for cardiac and noncardiac conditions to address the needs of people with congenital heart disease Evaluation 15 Develop and track key quality measures related to care for congenital heart disease and congenital heart disease-related population health 1. Infants with CHD are at increased risk for morbidity, mortality, and developmental disabilities not only in infancy, but also for decades later. 3. There is no nation-wide system for monitoring the number and health of people living with CHD. 4. There is no system to monitor outcomes of offspring of people with CHD, or to monitor the outcomes of pregnancies among women with CHD. 5. Limited information is available regarding racial, ethnic, and socioeconomic characteristics of people living with CHD.
Key Issues Related to Investigating Determinants and Modifiers
Primary Prevention at increased risk for mortality, driven by coronary artery disease, heart failure, and ventricular dysfunction. 43 3. Risk for coronary artery disease is related to age, hyperlipidemia, and hypertension. 44 Certain types of CHD, such as coarctation of the aorta, may increase the risk for hypertension. Exercise restrictions may increase the risk for obesity. Little is known about how to prevent or treat acquired heart disease in people with CHD.
Develop Interventions and Policies
Public health interventions and policies that focus on CHD can improve the health and well-being of people with CHD. Uniting and aligning efforts among stakeholders should accelerate effectively addressing CHD from a public health perspective. The CHPHC was formed in 2009 as an organization of stakeholders utilizing public health principles to affect change for those with CHD at the population level (http://www.chphc.org). 10, 11 The CHPHC has over 200 members, including individuals and organizations, as well as liaisons from key federal agencies (Table 2 ). The activities of the CHPHC are coordinated by the American Academy of Pediatrics, with support from the Centers for Disease Control and Prevention. Since inception, the CHPHC has accomplished multiple initiatives, such as assembling information to disseminate key facts, identifying databases available for CHD surveillance and research, and public awareness campaigns on various topics related to CHD. The CHPHC can play a key role in aligning efforts to advance a public health agenda to improve lives for those affected by CHD. To date, there are few specific policies or interventions designed to reduce the impact of CHD on the US population.
An exception is the implementation of newborn screening using pulse oximetry to detect critical CHD at birth and decrease infant mortality resulting from undiagnosed CHD. Fortification of cereals with folic acid, although aimed at preventing other birth defects (ie, neural tube defects), may prevent some CHD. 18 Because of the many gaps in current 
Implement and Evaluate
The measure of success of the public health approach aimed at improving both primary and secondary prevention is the extent to which it realizes a major reduction in the health impact of CHD in the entire population. While acknowledging that more research is needed, it is also important to develop and implement solutions based on what is already known. For example, maternal pregestational diabetes mellitus is an established risk factor for CHD, [51] [52] [53] and primary prevention targeting diabetes mellitus before conception is possible today. [54] [55] [56] It is also well established that diabetic women who are in optimal glycemic control immediately before and during pregnancy can reduce their risk of having a baby with CHD to nearly the level of those without pregestational diabetes mellitus. 51, 54, 55 More concerted efforts could be undertaken to target screening and management of diabetes mellitus among childbearingaged women at high risk of diabetes mellitus, with implementation of both individual-and population-level interventions. These efforts would include increasing awareness among childbearing-aged women and healthcare providers about the risk of CHD associated with pregestational diabetes mellitus, as well as improving access to screening and care for diabetes mellitus to increase the proportion of childbearing-aged women with pregestational diabetes mellitus in optimal glycemic control. Modeling has estimated that 2670 congenital heart defects could be prevented annually in the United States if interventions succeeded in ensuring all women with pregestational diabetes mellitus were in optimal glycemic control immediately before and during pregnancy. 52 Similarly, secondary prevention should include comprehensive strategies with policy changes that improve access to specialty care across the life span, such as individual-level education of cardiologists and patients regarding the importance of life-long specialty care. Programs to improve secondary outcomes may target specific populations, such as implementation of neurodevelopmental screening for all children with CHD, as well as neurocognitive care and preventive care for adult patients as they age. 32 Evaluation is instrumental in demonstrating program effectiveness and allowing effective pilot intervention programs to be expanded to reach a broader population. For example, newborn screening based on pulse oximetry for critical CHD in the United States began in 2011, and, as of 2015, 43 states had taken steps toward implementing universal screening. 57 The goal of critical CHD screening is to reduce morbidity and mortality associated with delayed diagnoses, and evaluation will be essential in quantifying the impact of this public health intervention. Similarly, screening children and adults with CHD for neurodevelopmental/neurocognitive and psychosocial issues will provide secondary prevention opportunities to reduce the health impact of CHD on individuals over their entire life span through appropriate therapeutic interventions. 23, 32, 33, 48, 58 Key Issues Related to Prevention Education 
Summary and Recommendations
A public health framework is presented to guide a public health agenda for CHD in the United States. The framework includes: (1) identification and investigation, including public health monitoring systems and population-based research; (2) development of interventions and policies, including aligning stakeholders, creating public systems and policies to reduce risk, improving outcomes, and ensuring equitable access and utilization of care; and (3) implementation and evaluation, including education and quality care programs; connecting individuals, health care, and ancillary services; and evaluation of systems. The CHPHC aligns key stakeholders as a publicprivate partnership to reduce death and disability from CHD across the life span. Collective efforts within the framework by CHPHC members are addressing all components with improved coordination (Figure 2 ). Key opportunities to advance a public health agenda for CHD are listed in Table 1 , including opportunities for research, monitoring, and implementation. The CHD population is growing, with significant risks, comorbidities, and enhanced need for healthcare resources. Knowledge gaps currently exist in many areas, and few policies and programs are specifically designed to reduce risk or improve outcomes for people with CHD. Future efforts aligned with the framework should accelerate knowledge and strategies to more rapidly reduce disease burden and improve outcomes at a population level for those affected by CHD.
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